A novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growthChetan K. Rane(Rutgers, The State University of New Jersey), Audrey Minden(Rutgers, The State University of New Jersey)Scientific ReportsFebruary 15, 201710.1038/srep42555Cited by 67SaveCiteExport RISWatch citationsRelated PapersThe Pak4 protein kinase is required for oncogenic transformation of MDA-MB-231 breast cancer cells|Oncogenesis|2013|50